Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.93 CAD -1.68% Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Cronos Group Inc?
Write Note

P/E
Price to Earnings

-13.9
Current
-5.7
Median
21.9
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-13.9
=
Market Cap
1.1B CAD
/
Net Income
-57.4m USD
All Countries
Close
Earnings Growth
CA
Cronos Group Inc
TSX:CRON
Average P/E: 33.2
Negative Multiple: -13.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.6
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35.4
86%
US
Johnson & Johnson
NYSE:JNJ
25.3
-22%
US
Merck & Co Inc
NYSE:MRK
21.2
7 321%
CH
Roche Holding AG
SIX:ROG
17.4
32%
UK
AstraZeneca PLC
LSE:AZN
31.8
177%
CH
Novartis AG
SIX:NOVN
11.5
21%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-18.9
2-Years Forward
P/E
-48.1
3-Years Forward
P/E
-11.3

See Also

Discover More